EcoDrugPlus

G-Protein Coupled Receptor 84-Like

Ensembl ID : ENSPREG00000016855
Gene Symbol: LOC103465383
3 Cross references
110 Possible Orthologues:

G-Protein Coupled Receptor 84-Like

Ensembl ID : ENSPREG00000016843
Gene Symbol: LOC103465379
3 Cross references
110 Possible Orthologues:

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSPREG00000004723
Gene Symbol: HCK
3 Cross references
202 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSPREG00000020456
Gene Symbol: ITK
3 Cross references
205 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSPREG00000020413
Gene Symbol: JAK1
3 Cross references
212 Possible Orthologues:

Janus Kinase 2

Ensembl ID : ENSPREG00000009040
Gene Symbol: JAK2
3 Cross references
199 Possible Orthologues:

Janus Kinase 2

Ensembl ID : ENSPREG00000008335
Gene Symbol: JAK2
3 Cross references
194 Possible Orthologues:

Kras Proto-Oncogene, Gtpase

Ensembl ID : ENSPREG00000018287
Gene Symbol: KRAS
3 Cross references
207 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSPREG00000003843
Gene Symbol: MAPKAPK2
3 Cross references
187 Possible Orthologues:

Mapk Activated Protein Kinase 5

Ensembl ID : ENSPREG00000014764
Gene Symbol: MAPKAPK5
3 Cross references
179 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSPREG00000008356
Gene Symbol: MKNK2
3 Cross references
208 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSPREG00000021916
Gene Symbol: MDM2
3 Cross references
275 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).